Neurotoxicity of MDMA and Related Compounds: Anatomic Studies a

The cytotoxic effects of amphetamine derivatives were studied by immunocytochemistry to identify the cellular compartments affected by these drugs, to obtain morphologic evidence of neuronal degeneration, and to assess the potential for regeneration. The substituted amphetamines, MDA, MDMA, PCA, and fenfluramine, all release serotonin and cause acute depletion of 5-HT from most axon terminals in forebrain. (1) Unequivocal signs of axon degeneration were seen at 36-48 hour survivals: 5-HT axons exhibited increased caliber, huge, swollen varicosities, fragmentation, and dilated proximal axon stumps. (2) Fine 5-HT axon terminals were persistently lost after drug administration, while beaded axons and raphe cell bodies were spared. These two types of 5-HT axons, which arise from separate raphe nuclei and form distinct ascending projections, are differentially vulnerable to psychotropic drugs. (3) From 2-8 months after treatment, there was progressive serotonergic re-innervation of neocortex along a fronto-occipital gradient. Longitudinal 5-HT axons grew into layers I and VI from rostral to caudal, before sprouting into middle cortical layers; this bilaminar pattern of growth simulates perinatal development of 5-HT innervation. This study demonstrates differential vulnerability of 5-HT projections, evidence for axonal degeneration, and sprouting of 5-HT axons leading to re-innervation of forebrain. While the sprouting axons are anatomically similar to the type that was damaged, it is not known whether a normal pattern of innervation is re-established.

[1]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.

[2]  C J CLEMEDSON,et al.  DYNAMIC RESPONSE OF CHEST WALL AND LUNG INJURIES IN RABBITS EXPOSED TO AIR SHOCK WAVES OF SHORT DURATION. , 1964, Acta physiologica Scandinavica. Supplementum.

[3]  K. Fuxe,et al.  THE DISTRIBUTION OF ADRENERGIC NERVE FIBRES TO THE BLOOD VESSELS IN SKELETAL MUSCLE. , 1965, Acta physiologica Scandinavica.

[4]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM. , 1965, Acta physiologica Scandinavica. Supplementum.

[5]  Lars Olson,et al.  Ascending Monoamine Neurons to the Telencephalon and Diencephalon , 1966 .

[6]  U. Ungerstedt.  Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.

[7]  A. Björklund,et al.  Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. , 1973, Acta physiologica Scandinavica. Supplementum.

[8]  C. Leonard,et al.  Connections of the median and dorsal raphe nuclei in the rat: An autoradiographic and degeneration study , 1974, The Journal of comparative neurology.

[9]  K. Perry,et al.  Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. , 1975, European journal of pharmacology.

[10]  E. sanders-Bush,et al.  Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. , 1975, The Journal of pharmacology and experimental therapeutics.

[11]  V. Chan‐Palay.  The Indoleamine Afferent Axons to the Cerebellum , 1977 .

[12]  E. sanders-Bush,et al.  IMMEDIATE AND LONG‐TERM EFFECTS OF p‐CHLOROAMPHETAMINE ON BRAIN AMINES * , 1978, Annals of the New York Academy of Sciences.

[13]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[14]  F. Bloom,et al.  Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study , 1978, Brain Research.

[15]  H. Joosten,et al.  Localization of serotonin in the central nervous system by immunohistochemistry: Description of a specific and sensitive technique and some applications , 1978, Neuroscience.

[16]  B. Srebro,et al.  LONG‐TERM BIOCHEMICAL AND BEHAVIORAL EFFECTS OF p‐CHLOROAMPHETAMINE IN THE RAT , 1978, Annals of the New York Academy of Sciences.

[17]  E. sanders-Bush,et al.  Long-term effects of fenfluramine on central serotonergic mechanisms , 1979, Neuropharmacology.

[18]  L. Seiden,et al.  Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study , 1980, Brain Research.

[19]  M. Molliver,et al.  The serotonin innervation of the cerebral cortex in the rat—an immunohistochemical analysis , 1980, Neuroscience.

[20]  A. Beaudet,et al.  Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine , 1981, Neuroscience.

[21]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[22]  R. Guillery,et al.  Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain , 1982, Brain Research.

[23]  F E Bloom,et al.  Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Steinbusch,et al.  Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain , 1982, Neuroscience.

[25]  S. Foote,et al.  The serotonin and norepinephrine innervation of primary visual cortex in the cynomolgus monkey (Macaca fascicularis) , 1984, The Journal of comparative neurology.

[26]  C. Rebert,et al.  Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey , 1984, Brain Research.

[27]  M. Molliver,et al.  Organization of raphe-cortical projections in rat: A quantitative retrograde study , 1984, Brain Research Bulletin.

[28]  L. Seiden,et al.  Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. , 1985, Science.

[29]  M. P. Johnson,et al.  Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. , 1986, European journal of pharmacology.

[30]  G. Hanson,et al.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. , 1986, European journal of pharmacology.

[31]  S. T. Kitai,et al.  The organization of divergent axonal projections from the midbrain raphe nuclei in the rat , 1986, The Journal of comparative neurology.

[32]  M. Molliver.  Serotonergic Neuronal Systems: What Their Anatomic Organization Tells Us about Function , 1987, Journal of clinical psychopharmacology.

[33]  E. D. De Souza,et al.  3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.

[34]  B. Kosofsky,et al.  The serotoninergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphe nuclei , 1987, Synapse.

[35]  L. Seiden,et al.  5,6-dihydroxytryptamine, a serotonergic neutotoxin, is formed endogenously in the rat brain , 1987, Brain Research.

[36]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[37]  L S Seiden,et al.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[38]  M. Wilson,et al.  (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. , 1988, JAMA.

[39]  M. Molliver,et al.  Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA) , 1988, Experimental Neurology.

[40]  G. Battaglia,et al.  Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  I. Törk,et al.  Serotoninergic innervation of the cat cerebral cortex , 1988, The Journal of comparative neurology.

[42]  M. Molliver,et al.  Neurotoxic effects of p-chloroamphetamine on the serotoninergic innervation of the trigeminal motor nucleus: a retrograde transport study , 1988, Brain Research.

[43]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[44]  G. Hanson,et al.  Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. , 1988, The Journal of pharmacology and experimental therapeutics.

[45]  G. Hanson,et al.  Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. , 1988, The Journal of pharmacology and experimental therapeutics.

[46]  M. Wilson,et al.  Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine , 1989, Neuroscience.

[47]  E. B. Souza.  Pharmacology and toxicology of amphetamine and related designer drugs. , 1989, NIDA research monograph.

[48]  M. Molliver,et al.  Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain , 1989, Experimental Neurology.

[49]  J. Fritschy,et al.  Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals , 1989, Neuroscience.

[50]  M. Molliver,et al.  Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat , 1990, Brain Research.

[51]  V. Chan‐Palay,et al.  Immunohistochemical localization of serotonin nerve terminals in the lateral entorhinal cortex of the rat: Demonstration of two separate patterns of innervation from the midbrain raphe , 2004, Anatomy and Embryology.